<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2665-0150</journal-id>
<journal-title><![CDATA[Más Vita. Revista de Ciencias de la Salud]]></journal-title>
<abbrev-journal-title><![CDATA[MasVita]]></abbrev-journal-title>
<issn>2665-0150</issn>
<publisher>
<publisher-name><![CDATA[A.C. Venezolana de Investigación Social en Pro de la Humanidad. ACVENISPROH]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2665-01502025000400008</article-id>
<article-id pub-id-type="doi">10.47606/acven/mv0294</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Benzodiacepinas en ansiedad: Revisión bibliográfica sobre efectos terapéuticos y riesgos]]></article-title>
<article-title xml:lang="en"><![CDATA[Benzodiazepines in Anxiety: A Literature Review on Therapeutic Effects and Risks]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Maldonado Encalada]]></surname>
<given-names><![CDATA[Yomara Solange]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramón Japón]]></surname>
<given-names><![CDATA[Geovanny Efrén]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez Prado]]></surname>
<given-names><![CDATA[Raquel Estefanía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jaramillo Procel]]></surname>
<given-names><![CDATA[Grace Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Técnica de Machala  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Técnica de Machala  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Técnica de Machala  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad Técnica de Machala  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>7</volume>
<numero>4</numero>
<fpage>8</fpage>
<lpage>17</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_arttext&amp;pid=S2665-01502025000400008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_abstract&amp;pid=S2665-01502025000400008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://ve.scielo.org/scielo.php?script=sci_pdf&amp;pid=S2665-01502025000400008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  Las benzodiacepinas son fármacos ampliamente prescritos para los trastornos de ansiedad por sus efectos ansiolíticos, hipnóticos y anticonvulsivantes; no obstante, su uso prolongado implica riesgos clínicamente relevantes.  Objetivo:  Analizar el papel de las benzodiacepinas en el tratamiento de los trastornos de ansiedad, considerando su eficacia clínica y los efectos adversos asociados.  Materiales y métodos:  Se efectuó una revisión bibliográfica de la literatura publicada entre 2019 y 2024 en PubMed, Scopus y Cochrane Library. Se identificaron 42 artículos científicos, de los cuales 25 correspondieron a revisiones sistemáticas o meta análisis, 10 a ensayos clínicos y 7 a estudios observacionales, priorizando aquellos con mayor calidad metodológica y relevancia clínica.  Resultados:  Las benzodiacepinas demostraron eficacia en el alivio rápido de los síntomas de ansiedad aguda (90% de los estudios) y en el manejo del insomnio y las crisis convulsivas. Sin embargo, su uso prolongado se asoció con dependencia en hasta el 60% de los casos revisados, deterioro cognitivo progresivo y mayor riesgo de caídas en adultos mayores, especialmente en presencia de polifarmacia.  Conclusiones:  El uso racional, de corta duración y bajo estricta supervisión médica, junto con intervenciones no farmacológicas como la psicoterapia cognitivo-conductual, es esencial para optimizar la seguridad y efectividad de las benzodiacepinas en la práctica clínica contemporánea.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Benzodiazepines are widely prescribed drugs for anxiety disorders due to their anxiolytic, hypnotic, and anticonvulsant effects; however, their long-term use involves clinically relevant risks.  Objective:  To analyze the role of benzodiazepines in the treatment of anxiety disorders, considering their clinical efficacy and associated adverse effects.  Materials and Methods:  A bibliographic review was conducted of the literature published between 2019 and 2024 in PubMed, Scopus, and Cochrane Library. A total of 42 scientific articles were identified, including 25 systematic reviews or meta-analyses, 10 clinical trials, and 7 observational studies, prioritizing those with high methodological quality and clinical relevance.  Results:  Benzodiazepines showed efficacy in the rapid relief of acute anxiety symptoms (90% of the studies) and in the management of insomnia and seizure disorders. However, chronic use was associated with dependence in up to 60% of reported cases, progressive cognitive impairment, and increased risk of falls among older adults, especially in the presence of polypharmacy.  Conclusions:  Rational, short-term, and medically supervised use-combined with non-pharmacological interventions such as cognitive-behavioral therapy-is essential to optimize the safety and effectiveness of benzodiazepines in contemporary clinical practice.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Benzodiacepinas]]></kwd>
<kwd lng="es"><![CDATA[trastornos de ansiedad]]></kwd>
<kwd lng="es"><![CDATA[deprescripción]]></kwd>
<kwd lng="es"><![CDATA[uso racional de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[psicoterapia cognitivo-conductual]]></kwd>
<kwd lng="en"><![CDATA[benzodiazepines]]></kwd>
<kwd lng="en"><![CDATA[anxiety disorders]]></kwd>
<kwd lng="en"><![CDATA[deprescribing]]></kwd>
<kwd lng="en"><![CDATA[rational use of medicines]]></kwd>
<kwd lng="en"><![CDATA[cognitive behavioral therapy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bandelow]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Michaelis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wedekind]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of anxiety disorders]]></article-title>
<source><![CDATA[Dialogues Clin Neurosci]]></source>
<year>2017</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-107</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dell&#8217;osso]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lader]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Do Benzodiazepines Still Deserve a Major Role in The Treatment of Psychiatric Disorders? A Critical Reappraisal]]></article-title>
<source><![CDATA[European Psychiatry]]></source>
<year>2013</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>7-20</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldwin]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Aitchison]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bateson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Curran]]></surname>
<given-names><![CDATA[HV]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Leonard]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines: Risks and benefits. A reconsideration]]></article-title>
<source><![CDATA[Journal of Psychopharmacology]]></source>
<year>2013</year>
<volume>27</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>967-71</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reeve]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Petrovic]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gnjidic]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people]]></article-title>
<source><![CDATA[Eur J Clin Pharmacol]]></source>
<year>2017</year>
<volume>73</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>927-35</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurko]]></surname>
<given-names><![CDATA[TAT]]></given-names>
</name>
<name>
<surname><![CDATA[Saastamoinen]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Tähkäpää]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tuulio-Henriksson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taiminen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tiihonen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies]]></article-title>
<source><![CDATA[European Psychiatry]]></source>
<year>2015</year>
<volume>8</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>1037-47</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parr]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Kavanagh]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cahill]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[RMcD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta&#8208;analysis]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>2009</year>
<volume>104</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>13-24</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gacsályi]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Móricz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gigler]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Wellmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nagy]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ling]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Behavioural pharmacology of the &#945;5-GABA A receptor antagonist S44819: Enhancement and remediation of cognitive performance in preclinical models]]></article-title>
<source><![CDATA[Neuropharmacology]]></source>
<year>2017</year>
<volume>125</volume>
<page-range>30-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stimpfl]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Mills]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Strawn]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacologic predictors of benzodiazepine response trajectory in anxiety disorders: a Bayesian hierarchical modeling meta-analysis]]></article-title>
<source><![CDATA[CNS Spectr]]></source>
<year>2023</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-60</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine Use and the Risk of Dementia in Middle-Aged and Older Patients with Chronic Insomnia]]></article-title>
<source><![CDATA[JAMA Netw Open]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofe]]></surname>
<given-names><![CDATA[I vom]]></given-names>
</name>
<name>
<surname><![CDATA[Stricker]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Vernooij]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Ikram]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Ikram]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Wolters]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study]]></article-title>
<source><![CDATA[BMC Med]]></source>
<year>2024</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>266</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markota]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rummans]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Bostwick]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Lapid]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies]]></article-title>
<source><![CDATA[Mayo Clin Proc]]></source>
<year>2016</year>
<volume>91</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1632-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voshaar]]></surname>
<given-names><![CDATA[RCO]]></given-names>
</name>
<name>
<surname><![CDATA[Gorgels]]></surname>
<given-names><![CDATA[WJMJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mol]]></surname>
<given-names><![CDATA[AJJ]]></given-names>
</name>
<name>
<surname><![CDATA[Van Balkom]]></surname>
<given-names><![CDATA[AJLM]]></given-names>
</name>
<name>
<surname><![CDATA[Van De Lisdonk]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Breteler]]></surname>
<given-names><![CDATA[MHM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial]]></article-title>
<source><![CDATA[British Journal of Psychiatry]]></source>
<year>2003</year>
<volume>182</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>498-504</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldwin]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of benzodiazepines in generalized anxiety disorder: a reappraisal]]></article-title>
<source><![CDATA[BMJ (British Medical Journal)]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soyka]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of benzodiazepine dependence]]></article-title>
<source><![CDATA[Massachusetts Medical Society]]></source>
<year>2021</year>
<volume>384</volume>
<page-range>1833-42</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schweizer]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rickels]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Case]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Greenblatt]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term benzodiazepine use and withdrawal in anxiety disorders]]></article-title>
<source><![CDATA[Pharmacopsychiatry]]></source>
<year>2020</year>
<volume>53</volume>
<page-range>65-72</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Leung]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Yiu]]></surname>
<given-names><![CDATA[HHE]]></given-names>
</name>
<name>
<surname><![CDATA[Deng]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A decade of Benzodiazepine and Z-drug use in Hong Kong: a longitudinal study]]></article-title>
<source><![CDATA[Lancet Reg Health West Pac]]></source>
<year>2025</year>
<volume>59</volume>
<page-range>101591</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Votaw]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
<name>
<surname><![CDATA[Geyer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rieselbach]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[McHugh]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemiology of benzodiazepine misuse: A systematic review]]></article-title>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>2019</year>
<volume>200</volume>
<page-range>95-114</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[M-J]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[Y-H]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[C-L]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[C-W]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[W-C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine exposure and risk of falls in older adults: A nationwide population-based case-control study]]></article-title>
<source><![CDATA[BMC Geriatr]]></source>
<year>2022</year>
<volume>22</volume>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hestevik]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Evensen]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Kornør]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Skeie]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review]]></article-title>
<source><![CDATA[BMC Psychiatry]]></source>
<year>2024</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>741</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rae]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Montagu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pauly]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Pottie]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deprescribing benzodiazepines: patient perspectives and experiences]]></article-title>
<source><![CDATA[British Journal of General Practice]]></source>
<year>2023</year>
<volume>73</volume>
<page-range>123-31</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Leong]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lader]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soyka]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Reeve]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults]]></article-title>
<source><![CDATA[EClinicalMedicine]]></source>
<year>2024</year>
<volume>69</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
